Comera Life Sciences Holdings, Inc. (CMRA)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 |
|---|---|---|---|
| Operating Cash Flow | -9.77 Million | -3.75 Million | -1.8 Million |
| Net Income | -18 Million | -5.45 Million | -2.12 Million |
| Depreciation & Amortization | 93.94 Thousand | 86.13 Thousand | 89.74 Thousand |
| Deferred income taxes | - | -160.58 Thousand | 1392.00 |
| Stock-based compensation | 375.79 Thousand | 1.11 Million | 101.04 Thousand |
| Change in working capital | 2.55 Million | 574.2 Thousand | -41.89 Thousand |
| Other non-cash items | 5.21 Million | 79.42 Thousand | 171.1 Thousand |
| Investing Cash Flow | -28.6 Thousand | -142.01 Thousand | -12.36 Thousand |
| Investments in PPE | -28.6 Thousand | -142.01 Thousand | -12.36 Thousand |
| Acquisitions | - | - | - |
| Investment purchases | - | - | -107.08 Million |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | - | - | - |
| Financing Cash Flow | 5.24 Million | 10.27 Million | 1.55 Million |
| Debt repayment | -1.06 Million | -750 Thousand | -160.58 Thousand |
| Dividends payments | - | - | - |
| Common Stock Repurchased | 650 Million | - | - |
| Common Stock Issuance | 829.46 Thousand | 9.52 Million | 1.39 Million |
| Other Financing Activities | 5.24 Million | 10.27 Million | 160.58 Thousand |
| Accounts receivables | -34.32 Thousand | 109.86 Thousand | -113.06 Thousand |
| Accounts payables | 862.92 Thousand | 319.32 Thousand | 20.98 Thousand |
| Inventory | - | 173.96 Thousand | 76.24 Thousand |
| Other working capital | 1.72 Million | -28.94 Thousand | -26.05 Thousand |
| Cash at beginning of period | 6.56 Million | 180.42 Thousand | 444.56 Thousand |
| Cash at end of period | 2 Million | 6.56 Million | 180.42 Thousand |
| Capital Expenditure | -28.6 Thousand | -142.01 Thousand | -12.36 Thousand |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | -4.55 Million | 6.37 Million | -264.14 Thousand |
| Free Cash Flow | -9.8 Million | -3.89 Million | -1.81 Million |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.15 Million | -1.41 Million | -2.48 Million | -18 Million | -2.96 Million | -3.07 Million |
| Depreciation & Amortization | 22.99 Thousand | 24.84 Thousand | 28.26 Thousand | 93.94 Thousand | 23.76 Thousand | 23.79 Thousand |
| Deferred income taxes | -9325.00 | -72.59 Thousand | - | - | - | - |
| Stock-based compensation | 267.56 Thousand | 278.96 Thousand | 300.76 Thousand | 375.79 Thousand | 148.8 Thousand | 127.69 Thousand |
| Change in working capital | -42.95 Thousand | 185.48 Thousand | 271.87 Thousand | 2.55 Million | 994.95 Thousand | 384.83 Thousand |
| Other non-cash items | 1408.00 | 1408.00 | -25.35 Thousand | 5.21 Million | -52.69 Thousand | 151.08 Thousand |
| Investing Cash Flow | - | -5650.00 | -88.35 Thousand | -28.6 Thousand | -28.57 Million | -25.15 Thousand |
| Investments in PPE | -2.00 | -5650.00 | -88.35 Thousand | -28.6 Thousand | -28.58 Million | -25.15 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | 11.46 Thousand | - |
| Financing Cash Flow | 3.2 Million | -63.19 Thousand | 1.58 Million | 5.24 Million | 1.13 Million | 145.16 Thousand |
| Debt repayment | -194.93 Thousand | -62.99 Thousand | -455.56 Thousand | -1.06 Million | -455.56 Thousand | -604.87 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -453 Thousand | -208.00 | - | 650 Million | 650 Million | - |
| Common Stock Issuance | 3.85 Million | -208.00 | 49.15 Thousand | 829.46 Thousand | 80.58 Thousand | 750.03 Thousand |
| Other Financing Activities | 3.2 Million | -62.99 Thousand | 1.53 Million | 5.24 Million | 1.13 Million | 145.16 Thousand |
| Accounts receivables | 250 Thousand | -250 Thousand | 34.32 Thousand | -34.32 Thousand | 259.5 Thousand | -193.82 Thousand |
| Accounts payables | -733.09 Thousand | 360.87 Thousand | 126.42 Thousand | 862.92 Thousand | -156.83 Thousand | 36.11 Thousand |
| Inventory | 476.44 Thousand | 38.3 Thousand | - | - | - | - |
| Other working capital | -36.31 Thousand | 36.31 Thousand | 111.13 Thousand | 1.72 Million | 892.28 Thousand | 542.54 Thousand |
| Cash at beginning of period | 526.3 Thousand | 1.58 Million | 2 Million | 6.56 Million | 2.71 Million | 4.98 Million |
| Cash at end of period | 1.81 Million | 526.3 Thousand | 1.58 Million | 2 Million | 2 Million | 2.71 Million |
| Capital Expenditure | -2.00 | -5650.00 | -88.35 Thousand | -28.6 Thousand | -28.58 Million | -25.15 Thousand |
| Effect of forex changes on cash | - | - | - | - | 28.57 Million | - |
| Net cash flow / Change in cash | 1.29 Million | -1.06 Million | -413.57 Thousand | -4.55 Million | -717.12 Thousand | -2.26 Million |
| Free Cash Flow | -1.91 Million | -999.15 Thousand | -1.99 Million | -9.8 Million | -30.42 Million | -2.41 Million |
MAH
AUEEF
8250
0403
PPLFY
MET-PA